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The interferon-inducible transmembrane (Ifitm/Fragilis) genes encode homologous pro-
teins that are induced by IFNs. Here, we show that IFITM proteins regulate murine
CD4+ Th cell differentiation. Ifitm2 and Ifitm3 are expressed in wild-type (WT) CD4+
T cells. On activation, Ifitm3 was downregulated and Ifitm2 was upregulated. Resting
Ifitm-family-deficient CD4+ T cells had higher expression of Th1-associated genes than
WT and purified naive Ifitm-family-deficient CD4+ T cells differentiated more efficiently
to Th1, whereas Th2 differentiation was inhibited. Ifitm-family-deficient mice, but not
Ifitm3-deficient mice, were less susceptible than WT to induction of allergic airways dis-
ease, with a weaker Th2 response and less severe disease and lower Il4 but higher Ifng
expression and IL-27 secretion. Thus, the Ifitm family is important in adaptive immunity,
influencing Th1/Th2 polarization, and Th2 immunopathology.
Keywords: Allergic airway disease  IFN-γ  Interferon-inducible transmembrane (IFITM)
protein  T helper 1 (Th1)  T helper 2 (Th2)
 Additional supporting information may be found online in the Supporting Information sectionat the end of the article.
Introduction
The family of interferon-inducible transmembrane (Ifitm/Fragilis)
genes (Ifitm1, 2, 3, 5, and 6) encode homologous proteins that
have recently been shown to confer cellular resistance to viruses
Correspondence: Dr. Tessa Crompton
e-mail: t.crompton@ucl.ac.uk
[1]. Their promoters have one or more interferon stimulated
response elements (ISRE), which make them responsive to IFNs
[2]. The IFITM family are also associated with germ cell specifica-
tion during mouse embryonic development [3–5], and may play a
role in the immune system, as in human cells, early cross-linking
antibody studies suggested that the IFITM1 protein (Leu13) was
involved in T-cell activation [6].
In tissue culture experiments, IFITM proteins enable cells to
resist infection by both enveloped and nonenveloped viruses, and
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several distinct mechanisms have been proposed to explain their
ability to increase cellular resistance to different viruses [1, 7–11].
In vivo studies showed that Ifitm3–/– confers resistance to
influenza infection in both humans and mice [12–15] but the
role of IFITM proteins in adaptive immunity per se has not been
explored. Here, we investigate the function of the IFITM family
in CD4+ Th cell differentiation. We show that Ifitm2 is rapidly
upregulated following T-cell activation, and that IFITM proteins
promote Th2 differentiation and inhibit Th1 differentiation in a
T-cell intrinsic manner. In the absence of IFITM proteins, the Th2
response is diminished in allergic airway disease, reducing the
severity of disease, but deletion of Ifitm3 alone does not reduce
disease severity. These findings demonstrate an important role for
IFITM proteins in adaptive immunity, in the cell-intrinsic regula-
tion of CD4+ Th differentiation and fate.
Results
Absence of IFITM proteins favors a Th1
transcriptional profile
To explore a possible function for the IFITM family in CD4+ T-cell
activation or differentiation, we first measured expression of the
Ifitm genes by RNA sequencing from CD4+ T cells for a 24 h time
course following in vitro activation with anti-CD3 and anti-CD28
in Th0/Th1/Th2 skewing-conditions (GEO: GSE93915; Fig. 1A).
This time-course analysis showed that Ifitm1 was expressed at
low levels throughout the time course in all conditions. At the
start of the experiment, Ifitm3 was most highly expressed of the
three genes, but it was then rapidly downregulated after 4 h in
response to the TCR/CD28 stimulus. In contrast, after an initial
downregulation, expression of Ifitm2 increased to above resting
levels, with highest expression overall in Th1 skewing conditions.
Expression of all three Ifitm1–3 genes was lower in the Th2 culture
conditions than Th0 and Th1 conditions from 4 h after stimulation
onwards, consistent with the fact that they are IFN response genes,
and that the Th2 skewing culture conditions include an anti-IFN-γ
mab. Ifitm5 was below detection, whereas Ifitm6 was expressed at
very low levels in resting CD4+ T cells and rapidly downregulated
after 4 h to below detection levels in all culture conditions.
Given the expression patterns of Ifitm2 and Ifitm3 in CD4+
T-cells in response to TCR/CD28 ligation, we tested if the IFITM
family are involved in CD4+ T-cell activation in vitro, but on
anti-CD3/CD28 stimulation, we found no differences in expres-
sion of activation markers or in proliferation between WT CD4+
T-cells and IFITM-deficient CD4+ T cells (from mice in which the
entire Ifitm gene family had been deleted [IfitmF–/–]) (Supporting
Information Fig. 1A–D).
Therefore, to investigate further the function of these genes in
CD4+ T cells, we carried out whole genome transcriptome anal-
ysis on purified CD4+ T cells from spleen of IfitmF–/– and WT to
identify common effects of Ifitm genes in resting CD4+ T cells
(GEO: GSE90494). We identified 920 differentially expressed
genes (DEG) between WT and IfitmF–/– (Fig. 1B). As expected,
these included the Ifitm family members, Ifitm1, Ifitm2, and Ifitm3,
which were below detection threshold in the knockout (Fig. 1C).
In order to explore the molecular variability between the two
genotypes in an unbiased way, we carried out principal compo-
nent analysis. The first principal component axis (PC1), which
accounted for 52.7% of variability within the dataset, separated
the samples by genotype (Fig. 1D). We then identified genes-of-
interest, by intersecting the 1000 genes that contributed most to
PC1 with the 920 DEG (Fig. 1E; Supporting Information Table 1).
This intersection included genes for the costimulatory molecule
CD27, which can sensitize na¨ıve T cells to Th1 differentiation
through interactions with CD70 on APC, and the transcription
factor Stat1, which plays an important role in IFN-γ signal trans-
duction [16, 17] (Fig. 1E). Given that Cd27 and Stat1 are both
involved in the Th1 response, we examined expression of other
genes known to be associated with Th1 or Th2 responses [18].
We found significant increase in expression in the IfitmF–/– CD4+
T cells compared to WT of Th1-associated genes such as Cd84,
Cd226, and Cd154 and also Il27ra, which signals for Stat1 activa-
tion during early Th1 differentiation [19–21], whereas there was
no difference in expression levels of the master Th1 transcription
factor Tbx21 between genotypes (Fig. 1F). Interestingly, expres-
sion of the Th2-associated genes Il4ra, ICOS, Irf4, and the Th2-
transcription factor Gata3 were significantly lower in the IfitmF–/–
cells (Fig. 1F). Thus, the transcriptome data suggested an over-
all reduction in expression of Th2-associated genes and a ten-
dency toward increased expression of Th1-associated genes in the
IfitmF–/– CD4+ T cells compared to WT (Fig. 1F).
To test this idea on a wider gene set, we generated a scale
of Th2-to-Th1 skewedness (Th2→Th1 score) and plotted our
datasets against this scale using canonical correspondence analy-
sis (CCA), as previously described [22]. The scale was generated
from the thousand most DEG (by eBayes) between Th1 and Th2
CD4+ T cells in publically available whole genome transcriptome
data derived from Th-skewed cultures (GEO: GSE14308). Interest-
ingly, although the reference data were obtained from T cells that
had been cultured for several days in skewing conditions, IfitmF–/–
CD4+ T cells showed a clear bias toward the Th1 transcriptional
profile compared to the WT (Fig. 1G). Thus, these analyses sug-
gested that absence of the IFITM family of proteins predisposed
resting CD4+ T cells to Th1 differentiation in the spleen.
IFITM proteins polarize Th differentiation in vitro
Given the function significance of IFITM family deletion on the
transcriptome of resting CD4+ T cells, we next investigated Ifitm
expression in FACS-sorted na¨ıveWT CD4+ T cells by RNA sequenc-
ing, after anti-CD3/CD28 activation over a longer 30-h time course
(Fig. 2A). At 30 h after activation, expression of Ifitm2 was more
than tenfold higher than Ifitm1 and Ifitm3. As expected, expres-
sions Ifitm5 and Ifitm6 were very low.
To test whether the IFITM proteins influence Th differenti-
ation in a T-cell intrinsic manner, we FACS-sorted na¨ıve CD4+
T cells from IfitmF–/– and WT littermate mice and activated them
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Figure 1. Absence of IFITM proteins biases resting CD4+ T cells to a Th1-like transcriptional profile. (A) RNAseq was carried out on purified CD4+
T cells from WT spleen pooled from six mice, activated with anti-CD3 and anti-CD28 in skewing conditions, and cells were removed from the
cultures for RNA sequencing at 4 h time points after activation. Each different time point and culture conditions combination was sequenced
once to generate one dataset. Graphs show expression (RPKM). (B–F) Affymetrix microarray analysis was carried out on purified CD4+ T cells from
WT and IfitmF–/– spleen. Two datasets were obtained for each genotype from biological replicates and separate purifications. Cells purified from
two mice were pooled for each dataset. (B) Scatter plot: The relative change in expression (fold change) of significantly different genes (DEG with
p < 0.05 by eBayes, FDR adjusted, with a fold change greater than two) in IfitmF–/– compared to WT, plotted against the mean intensity (RMA
normalized value, plotted on a log2 scale). Selected genes have been marked on the plot. Red/blue dots represent increased/decreased expression
in the IfitmF–/– compared to WT; light red/light blue dots represent probes not annotated to any gene on the Affymetrix 1.0 ST platform. Both
the axes are on a log2 scale with the labels in the y-axis representing the nonlogarithmic relative fold changes in KO relative to WT mice. (C)
Relative expression (nonlog RMA normalized value, relative to mean of WT) in IfitmF–/– and WT CD4+ T cells. (Histograms show mean ± SEM; +
represents expression below detection threshold. *p < 0.05 by eBayes, FDR adjusted value. (D) Datasets for WT and IfitmF–/– plotted on PC1. (E) The
1000 genes that contributed most to PC1 were intersected with 920 DEG with a range of at least 250 units (nonlog RMA normalized) to identify
genes-of-interest, including Stat1 and Cd27. These genes are listed in supporting Information Table 1. (F) Normalized expression (nonlog RMA
normalized value, relative to mean of WT) in the IfitmF–/– and WT CD4+ T cells of the Th1 (left) and Th2 (right) associated genes listed. (Bar charts
show mean ± SEM; *p < 0.05; **p < 0.01, Student’s t-test). (G) CCA was used to plot samples on a scale of Th2→Th1 scale. The scale was generated
from Affymetrix datasets from in vitro-skewed Th2 and Th1 cells. On the scale, 0 is the mean value of WT samples; Th1 are positive.
with anti-CD3 and anti-CD28 in the different skewing conditions
(Fig. 2B). After 72 h in culture, intracellular Tbet expression was
increased in the IfitmF–/– Th0 cultures, compared to WT control,
suggesting a cell-intrinsic bias of na¨ıve CD4+ T cells toward Th1
differentiation in the absence of IFITM proteins. In Th1 skew-
ing conditions, the percentage of Tbet+ cells was also signifi-
cantly higher in IfitmF–/– compared to WT CD4+ T cells, showing
enhanced commitment to the Th1 lineage, whereas there was no
difference in Tbet expression under Th2 condition (Fig. 2B–C). In
contrast, expression of the Th2-transcription factor Gata3 was low
and equivalent between WT and IfitmF–/– CD4+ T cells cultured in
Th0 and Th1 conditions, and was lower in IfitmF–/– compared to
WT CD4+ T cells cultured in Th2 conditions (Fig. 2B and D). Anal-
ysis of gene expression by quantitative RT-PCR (qRT-PCR) also
showed that Tbx21 (Tbet) was more highly expressed in IfitmF–/–
Th1 cultures than in WT, whereas expression of Gata3 was lower
in IfitmF–/– Th2 cultures (Fig. 2E). We also observed a modest
but significant increase in expression of Il27ra in the Th1-skewed
IfitmF–/– cultures compared to WT (Fig. 2E), consistent with the
microarray analysis of resting CD4+ T-cells (Fig. 1F). Supporting
the Th1 profile, cell surface expression of the Th1 marker, Cxcr3,
was increased in Th1-skewing cultures cells from IfitmF–/– mice
compared to WT after 72 h of culture, and likewise there was
an increase in cell surface expression of CD54 (Icam1), which on
C© 2018 The Authors. European Journal of Immunology published by
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Figure 2. Absence of IFITM proteins biases CD4+ T cells to Th1 in vitro. (A) Expression (RPKM) by RNAseq of Ifitm genes in naı¨ve CD4+ T cells from
WT splenocytes, activated with anti-CD3/CD28. Two independent datasets were obtained for each time point from separate FACS sorts (n = 7 WT
mice). Data are shown as mean ± SEM. (B) Flow cytometry analysis of intracellular staining of Tbet and Gata3 from WT and IfitmF–/– on purified
naı¨ve CD4+ T cells cultured for 72 h in Th0, Th1 and Th2 conditions. Dot plots show the gating strategy to identify live CD4+ T cells at the end
of the culture period. Histograms show the percentage of positive cells in the marker for IfitmF–/– (black line) and WT (grey line). Naı¨ve CD4+
T cells were purified and cells from each individual mouse were cultured independently (WT n = 4 and IfitmF–/–n = 4 mice per experiment). (C)
Percentage of Tbet+ CD4+ T cells cultured in the three different polarizing conditions from WT and IfitmF–/– mice (n = 4 mice per group). Data are
shown as mean ± SEM and are representative of two independent experiments. (D) Percentage of Gata3+ cells in CD4+ T cells cultured in the three
different conditions fromWT and IfitmF–/– mice (n = 6 mice per group). Data are shown as mean ± SEM and are representative of two independent
experiments. (E) qRT-PCR after 72 h of culture of purified naı¨ve CD4+ T cells for expression of Tbet and Il27ra in Th1 conditions and Gata3 in
Th2 conditions. Units are arbitrary (Au). Data are shown as mean ± SEM from three independent experiments (n = 3 mice for each genotype per
experiment). (F) Histograms show cell surface expression of Cxcr3 under Th1 culture conditions for WT and IfitmF–/– CD4+ T cells. Bar charts show
mean ± SEM percentage of cells in the marker shown, and the MFI of cells in the marker shown from CD4+ T cells from WT (n = 3 mice) and
IfitmF–/– (n = 3 mice). Data shown are representative of three independent experiments. (G) (Left) Cell surface expression of CD54 from Th1 cultures
of CD4+ T cells from WT and IfitmF–/–. Data shown are representative of four independent experiments, (right) percentage of CD54+ cells gated on
CD4+ T cells from the cultures from WT (n = 4 mice) and IfitmF–/– (n = 4 mice). Data shown are representative of two independent experiments.
Grey histograms show staining with an isotype control antibody *p < 0.05, Student’s t-test.
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naive CD4+ T cells plays an important role in the early stages of
Th1 differentiation by regulation of IL-27 (Fig. 2F–G) [23].
The pattern of cytokine expression confirmed the Th1 bias of
the IfitmF–/– deficient CD4+ T cells. After 3 days of culture in
Th1 conditions, the proportion of CD4+ T cells that expressed
the key Th1 cytokine IFN-γ was significantly increased in IfitmF–/–
CD4+ T cells compared to littermate WT (Fig. 3A), whereas in Th0
conditions, very few cells expressed intracellular IFN-γ and there
was no difference between genotypes (Supporting Information
Fig. 1E). In contrast, the percentage of cells that expressed IL-4
and IL-13 was reduced in IfitmF–/– CD4+ T cells cultured for 3
days in Th2 conditions compared to WT (Fig. 3A).
After 6 days of culture in Th1 conditions, the percentage of
Tbet+ IFN-γ+ cells was also higher in IfitmF–/– CD4+ T cells com-
pared to WT (Fig. 3B), whereas the percentage of Gata3+ IL-4+
cells after 6 days of culture in Th2 conditions was lower in IfitmF–/–
CD4+ T cells compared to WT (Fig. 3C). Measurement of cytokine
secretion confirmed these findings, as the concentration of IFN-
γ was increased in supernatants from IfitmF–/– compared to WT
cultures after 6 days of culture in Th1 conditions (Fig. 3D), but
the concentration of IL-4 was lower after 6 days of culture in Th2
conditions (Fig. 3E).
Thus, na¨ıve CD4+ T cells purified from IfitmF–/– mice showed
a cell-intrinsic bias toward Th1 differentiation, with concomitant
repression of Th2 differentiation. These data suggest a negative
feedback loop between IFITM proteins and Th1-differentiation in
CD4+ T-cells: Ifitm genes are induced by IFN-γ, but in the absence
of IFITMs, IFN-γ expression and Th1 differentiation are favored.
Absence of IFITM proteins reduces the Th2 response
in a murine asthma model
Th1 cells can inhibit Th2-induced inflammation in the lung,
through production of IFN-γ [24, 25]. Since we found that the
absence of IFITM proteins promoted Th1 differentiation, with an
increase in IFN-γ levels, we used a murine model of allergic air-
ways disease to test whether the IFITM family is required for Th2-
induced effector functions in vivo. We used the allergen papain,
which is widely used as an asthma model to induce allergic airway
inflammation by promoting a Th2 response [26–29].
After repeated intranasal administration of papain or
phosphate-buffered saline (PBS; Supporting Information Fig. 2A),
bronchoalveolar lavage (BAL), lungs, and mediastinal lymph
nodes (mLN) were collected from WT and IfitmF–/– mice. As
expected, papain sensitization produced robust recruitment of
inflammatory cells to the BAL and lungs in both WT and IfitmF–/–
mice (Supporting Information Fig. 2B–C). The BAL from IfitmF–/–
contained significantly fewer cells than BAL from WT mice and
contained significantly fewer eosinophils and myeloid dendritic
cells (mDC) thanWT after papain challenge (Fig. 4A). The cellular
infiltration and number of eosinophils and mast cells isolated from
the lungs were also significantly lower in the IfitmF–/– mice than
WT, reflecting decreased severity of the inflammatory phase of dis-
ease (Fig. 4B). We observed no significant difference in the num-
bers of neutrophils between the WT and IfitmF–/– lungs (Fig. 4B).
Immunohistochemistry of lung tissue showed that the IfitmF–/–
lungs also had significantly lower cellular infiltration than WT
after papain treatment (Fig. 4C). Periodic acid–Schiff (PAS) stain-
ing showed that mucous production was suppressed in IfitmF–/–
compared to WT lungs (Fig. 4D).
Consistent with the induction of allergic airways disease,
Il4 expression in lung was upregulated on papain sensitization
(Fig. 4E). Expression of Il4 mRNA was lower in the homogenized
lungs of IfitmF–/– mice compared to WT, after papain challenge,
consistent with weaker induction of disease (Fig. 4E). In contrast,
Ifng expression was not significantly increased in WT lungs on
papain sensitization, but was upregulated in IfitmF–/– lungs, and
on papain treatment was significantly higher in IfitmF–/– than WT
lung (Fig. 4F).
In addition to the decrease in inflammatory cells in IfitmF–/–
lungs and BAL compared toWT,we observed a significant decrease
in the recruitment of CD4 and CD8 T cells in BAL in IfitmF–/– com-
pared to WT (Fig. 5A). There was a decrease in the percentage
of cells that expressed cell surface T1ST2, a marker of activated
Th2 cells [30] in mLN from papain-sensitized IfitmF–/– compared
to WT (Fig. 5B). Cell surface CD27 expression was significantly
increased on mLN CD4+ T cells from papain-treated IfitmF–/– com-
pared to WT (Fig. 5C), consistent with the higher expression of
Cd27 in resting CD4+ T cells from the IfitmF–/– spleen compared
to WT (Fig. 1F).
We then examined cytokine production on papain treatment.
The concentration of the Th2 cytokine IL-13 was significantly
lower in BAL from IfitmF–/– than WT (Fig. 5D). Interestingly,
the concentration of IL-27, which can promote IFN-γ produc-
tion through activation of Stat1, was higher in the IfitmF–/– BAL
(Fig. 5D). In lung homogenates, the Th2 cytokines, IL-5, IL-10, and
IL-6 were lower in IfitmF–/– than WT (Fig. 5E). In addition, there
were lower concentrations of proinflammatory cytokines TNF-α
and IL-17 in IfitmF–/– lungs compared to WT after papain treat-
ment (Fig. 5E). Thus, absence of the IFITM family reduced the
Th2-inflammatory effect in allergic airway disease.
Ifitm3 deletion does not reduce the Th2 response
As both Ifitm2 and Ifitm3 are regulated by TCR/CD28 ligation and
are more highly expressed in Th1-skewing conditions than neutral
or Th2-skewing conditions (Figs. 1A and 2A), it is possible that
it is the absence of either Ifitm2 or Ifitm3 that influences Th1/2
differentiation in the IfitmF–/– mice.
We therefore assessed expression of Th1-associated genes that
we had identified to be differentially expressed in CD4+ T cells
from IfitmF–/– spleen, in CD4+ T cells isolated from Ifitm3–/– and
WT spleen. We found no significant differences in expression of
Stat1, Cd84, or Cd27 between Ifitm3–/– and WT CD4+ T cells
purified fresh from the spleen (Fig. 6A) or cultured in skewing con-
ditions after 72 h (Fig. 6B–D). Likewise, there was no significant
difference in the proportion of Ifitm3–/– CD4+ T cells that stained
positive with intracellular anti-Tbet and anti-IFN-γ after 72-h
C© 2018 The Authors. European Journal of Immunology published by
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Figure 3. The absence of IFITM proteins promotes Th1 cytokine production and decreases Th2 cytokine production. (A) Purified naı¨ve CD4+ T cells
from IfitmF–/– and WT mice were cultured in vitro under Th1 and Th2 skewing conditions. Dot plots show the intracellular expression of IFN-γ
under Th1 conditions (above), IL-4 (middle), and IL-13 (bottom) under Th2 conditions in CD4+ T cells from WT and IfitmF–/– after 72 h of culture.
Data shown are representative of three independent experiments. In each case, the control plots show negative control. Bar charts show mean
± SEM percentage of cells that stained positive for each cytokine, for IFN-γ in IfitmF–/– (n = 6 mice) cultures compared to WT (n = 5 mice); and for
IL-13 and IL-4 (n = 3 mice per genotype). (B, C) Dot plots, representative of three experiments, show the intracellular expression in CD4+ T cells
fromWT and IfitmF–/– cultured for 6 days and stimulated as described in (A), showing (B) Tbet+IFN-γ+ in Th1 conditions and (C) Gata3+IL-4+ in Th2
conditions. The control plots show negative control. Bar charts show mean ± SEM. (D) Concentration of IFN-γ in supernatants from in vitro Th1
cultures after 6 days was measured by ELISA (n = 3 mice for each genotype). (E) Concentration of IL-4 in supernatants from in vitro Th2 cultures
after 6 days measured by ELISA. Data are shown as mean ± SEM (n = 3 samples) *p < 0.05, Student’s t-test.
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Figure 4. Absence of IFITM proteins decreases Th-2 immunopathology. WT and IfitmF–/– mice received intranasal challenge with PBS or papain
(described in the cartoon in Supporting Information Fig. 2A). (A) Bar charts show the mean ± SEM number of cells in BAL and mean number of
eosinophils andmDC in BAL. (B) Themean number of cells recovered from lungs (total lung, left side) andmean number of eosinophils, mast cells,
and neutrophils recovered from lung of WT and IfitmF–/– mice. (C, D) Representative examples of cellular infiltration and mucous production in
formalin-fixed paraffin-embedded lung sections ofWT (n = 3mice) and IfitmF–/– (n = 3mice) in PBS and papain conditions. A blind semiquantitative
histological assessment was performed to score cellular infiltration by H&E staining and mucous production by PAS staining. (C) H&E staining:
20× magnification; bar chart shows scale of cellular infiltration of airways, from 0 to 4 (arbitrary units). (D) PAS staining: 40× magnification; bar
chart shows scale of mucous production, from 0 to 3 (arbitrary units). (E, F) qRT-PCR for expression of Il4 (E) and (F) Infg in lung in PBS and papain
conditions in WT (n = 6 mice) and IfitmF–/– (n = 6 mice). Au = arbitrary units. Bar charts represent mean ± SEM. Data in (A, B, E, and F) are
representative of two independent experiments with five or six mice per genotype. ng, negligible; *p < 0.05, Student’s t-test.
C© 2018 The Authors. European Journal of Immunology published by
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Figure 5. Effect of IFITM deficiency on the Th2 population and cytokine production in the papain asthma model. (A) Flow cytometry analysis
of cells from BAL. Bar chart shows mean ±SEM number of CD4 and CD8 T cells in BAL from papain-treated WT and IfitmF–/–. (B) Dot plots show
anti-CD4 and T1ST2 staining, indicating the percentage of T1ST2+CD4+ T cells in the region shown from papain-treated WT and IfitmF–/– mLN.
Scatter plots show mean ±SEM percentage of T1ST2+CD4+ positive cells. Each dot represents an individual mouse. (C) Frequencies of cells in the
mLN from papain-treated WT and IfitmF–/–. Scatter plots show mean ± SEM percentage of CD27+CD4+ cells in mLN from papain-treated WT and
IfitmF–/–. Each dot represents an individual mouse (n = 6 per genotype). (D) Cytokine levels in BAL of PBS versus papain-treated WT (n = 6 mice)
and IfitmF–/– mice (n = 6 mice). (K) Quantification of inflammatory cytokines in lung homogenates from WT (n = 3) and IfitmF–/– (n = 3) mice in PBS
and papain conditions, error bars ± SEM. (A–C) Data are representative of two independent experiments with five to six mice per group in each.
nd, not detectable, *p < 0.05; **p < 0.01; ***p < 0.001, Student’s t-test.
activation of purified naive CD4+ T cells in Th1 skewing con-
ditions, compared to WT counterparts (Fig. 6E and F). This
experiment together with the gene expression studies suggests
that deletion of Ifitm3 alone does not predispose CD4+ T cells
to Th1 differentiation. To confirm this in vivo, we induced
allergic airways disease by intranasal papain administration, and
monitored cell infiltration into the lungs and BAL. There were
no significant differences in the numbers of eosinophils, DC, and
neutrophils in the BAL and lung. In contrast to the papain-treated
IfitmF–/– mice, we did, however, find a significant reduction
in the number of macrophages in the Ifitm3–/– BAL and of
macrophages and neutrophils in the papain-treated Ifitm3–/– lung
compared to WT (Fig. 6G–H). Finally, there were not significant
differences in the number of T cells (Fig. 6I–K) or in the number
of CD4+T1ST2+ cells (Fig. 6L) in BAL, lung, or mLN. Overall,
we found no evidence for Th1 bias in Ifitm3–/– mice, whereas
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Figure 6. Effect of IFITM3 on CD4+ T cell differentiation. (A–D) Relative expression of Stat1, Cd84, and Cd27 were measured by qRT-PCR of purified
CD4+ T cells in (A) resting conditions and (B–D) in CD4+ T cells cultured for 72 h in skewing conditions of WT and Ifitm3–/– mice. Bar charts show
mean expression ± SEM, relative to Hprt, units are arbitrary (Au). The bar charts show mean from three separate experiments carried out with
biological replicates. (E) Histogram shows intracellular Tbet protein expression in WT and Ifitm3–/– naı¨ve CD4+ T cells in Th1 skewing conditions
cultured for 72 h from a representative experiment of 3, for WT (n = 3 mice) and Ifitm3–/– (n = 3 mice). Bar charts show mean ± SEM percentage of
cells that stained positive for Tbet in WT and IfitmF–/–. (F) Dot plots show intracellular IFN-γ expression in purified naı¨ve CD4+ T cells from Ifitm3–/–
and WT under Th1 conditions for 72 h from a representative experiment of WT (n = 3 mice) and Ifitm3–/– (n = 3 mice). Bar chart shows mean
percentage of CD4+IFN-γ+ cells. (G–L) WT (n = 4) and Ifitm3–/– (n = 4) mice underwent intranasal challenge with papain and PBS. (E and F) Bar charts
show the mean ± SEM number of cells in BAL and lungs: macrophages (CD11blowCD11c+FSCintSSCint); eosinophils (CD11b+SiglecF+FSClowSSCint);
mDC (Gr1−CD317−CD11b+CD11c+) and neutrophils (CD11bhiCD11c−Ly6g+ FSClowSSClow). Bar charts show cell number of CD4, and CD8 T cells in
(I) BAL, (J) lungs, (K) mLN in WT, and Ifitm3–/– mice. (L) Quantification of T1ST2 in CD4+ T cells from BAL, lung, and mLN. Error bars ± SEM.
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deletion of the Ifitm family reduced induction of allergic airways
disease and the Th2 response.
Discussion
Here, we show that deletion of the Ifitm family biases CD4+ Th
differentiation to Th1 and reduces the severity of allergic airways
disease in amurinemodel of allergic asthma.Much recent research
on IFITM proteins has focused on their role in cellular resistance
to viral infections, but their function in CD4+ T cells during the
adaptive immune response is less well understood.
We showed that Ifitm1, 2, and 3 are expressed in peripheral
T cells, and that expression of Ifitm2 and Ifitm3 are differentially
regulated by TCR/CD28 ligation, with rapid downregulation of
Ifitm3 but upregulation of Ifitm2. In mice deficient in the Ifitm
family, resting CD4+ T cells had a transcriptional signature closer
to that of Th1 cells than WT, and sorted na¨ıve CD4+ T cells were
polarized toward Th1 differentiation in a cell-autonomousmanner
when cultured in vitro in Th-neutral and Th1 skewing conditions.
IFN-γ production was increased in vitro and on induction of aller-
gic airways disease, whereas Th2 responses were reduced. Thus,
the IFITM family seems to provide a negative feedback loop on Th1
differentiation in CD4+ T cells, as they are IFN-inducible proteins,
which function to limit Th1 differentiation.
Taken together, our experiments suggest that one or more of
the IFITM family of proteins act as negative regulators of Th1
differentiation and influence Th1/Th2 polarization. As the RNA-
sequencing data showed that Ifitm2 expression increased in CD4+
T cells during the first 30 h following activation, whereas Ifitm3
expression was rapidly downregulated, IFITM2 is the most likely
candidate. In support of this, we found no impact of Ifitm3 defi-
ciency alone on IFN-γ production or Th1 differentiation, and on
induction of allergic airways disease; there was no significant
impact of Ifitm3 deficiency on Th2 effector populations or on
eosinophil or mast cell infiltration of the lung. Therefore, these
experiments also indicate that Ifitm2 is most likely the key family
member that is required for Th2 differentiation and inhibition of
Th1 differentiation, although we cannot exclude a synergistic or
additive effect between IFITM proteins.
Genome-wide transcriptome analysis on purified CD4+ T cells
from the spleen of the IfitmF–/– and WT revealed insights into
causes of the enhanced Th1 response. Amongst DEG, we found the
Th1 transcription factor Stat1, which was significantly higher in
the IfitmF–/–, as was transcription of other Th1-associated genes,
such as Il27ra (WSX-1, Gp130), Cd27, and Cd84. Interestingly,
we detected no difference in Tbx21 (Tbet) transcription in rest-
ing CD4+ T cells, but Tbet expression was increased on activation
in IfitmF–/– CD4+ T cells compared to WT. As IFITM proteins are
transmembrane proteins that are found in intracellular and plasma
membranes, the way in which their deletion has such a profound
influence on the pattern of transcription is not immediately clear.
However, membrane fusion studies have suggested that IFITM
proteins block early steps of viral replication by influencing the
molecular order of membranes and membrane fluidity [11]. Inter-
estingly, plasma membrane lipid order may also be an important
factor that influences Th differentiation. High membrane order
is related to Th2 differentiation, with higher production of IL-
4, whereas intermediate membrane order is present in Th1 cells
secreting IFN-γ [31].
The absence of IFITM proteins may have a protective role
in allergic diseases, such as asthma, by inhibition of the Th2
response, decreasing the severity of the inflammatory process.
Several reports support the protective role of IFN-γ in airway
inflammation. IFN-γ can inhibit Th2 cytokine effects in the air-
way and reduces production of eosinophils and mucus overpro-
duction [24, 25]. We found that the absence of IFITM family
increased the level of Ifng in the lung, reduced cellular infiltra-
tion and Th2 cytokines, and attenuated inflammatory cytokine
production.
In addition to its effect on Th1 differentiation, IL-27 can play an
anti-inflammatory role in CD4+ T cells and is important in diseases
induced by Th2 or Th17 cells [32, 33]. IL-27 can suppress the
production of many different cytokines including IL-4, IL-5, IL-13,
IL-2, IL-6, IL-10, TNF-α, and IL-17 [34]. Interestingly, although
IL-27 production was increased in the IfitmF–/– mice compared
to WT in our asthma experiments, levels of Il4, IL-5, IL-13, IL-6,
IL-10, IL17, and TNF-α were all decreased.
Genome-wide association studies (GWAS) have indicated that
the Hedgehog (Hh) signaling pathway plays a role in allergic
asthma [35–38] and experimental mouse asthma studies have
shown that increased Hh signaling to T cells and eosinophils exac-
erbates the disease [39, 40]. Consistent with the reduction in
allergic airways disease observed in the IfitmF-deficient mice, both
Ifitm2 and Ifitm3 are Hh-target genes in CD4+ T cells [22]. In the
future, it will be interesting to dissect the interactions between Hh
pathway activation and IFITM function in asthma.
Many studies have shown that the IFITM family provides cel-
lular resistance to viral infection in vitro, and GWAS identified
IFITM3 as a resistance gene for influenza in humans [13, 41].
However, we show here that deletion of IFITM proteins reduces
the severity of Th2 inflammation in a mouse asthma model, sug-
gesting an evolutionary balance between conferring cellular viral
resistance and susceptibility to allergic disease. This study demon-
strates that the IFITM family of proteins should be viewed not only
as essential proteins for cellular resistance to viral infection but
also as important regulators of CD4+ Th cell differentiation and
function.
Materials and methods
Mice
Ifitm-family-deficient (IfitmF–/–) and Ifitm3-deficient (Ifitm3–/–)
mice were as described on a C57BL/6 background [2]. Mice were
bred and maintained at UCL. All mice studies were reviewed and
approved by the British Home Office.
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Flow cytometry
Cells were stained as described [42] using antibodies from eBio-
science or MD Biosciences and analyzed on a C6 Accuri flow
cytometer (BD, Switzerland). Live cells were gated according
to FSC/SSC profiles (as illustrated in Fig. 2B). For intracellular
cytokine staining, cells were stimulated with PMA (50 ng/mL;
Sigma, Sigma-Aldrich, USA), Ionomycin (1 μg/mL; Sigma), and
BrefeldinA (eBioscience) incubated in RPMI at 37°C for 4 h. Then,
cells were fixed (Cytofix) and permeabilized (Bioscience) to carry
out the intracellular staining for IFN-γ, IL-4, and IL-13. Anti-Tbet
and anti-Gata3 were staining as described [39] after fixation and
permeabilization (antibodies/protein: eBioscience San Diego, CA,
USA).
Cell cultures
For activation, splenocytes at 5 × 106 cells/mL were cultured in
AIM-Vmedium (Invitrogen, USA) with 10–5M β-mercaptoethanol
and anti-CD3/anti-CD28 (BD Pharmingen, USA) at 0.01 μg/mL
each. Cells were harvested at 4 and 20 h for analysis CD69 and
CD25. Carboxyfluorescein diacetate succinimidyl ester (CFSE)
labeling was carried out on splenocytes as previously described
[22], then cells stimulated with anti-CD3 and anti-CD28 antibod-
ies at 0.01 μg/mL and analyzed after 72 h.
For in vitro Th skewing experiments, splenocytes were treated
with RBC lysis buffer before CD4+ T cells and pooled lymph nodes
were purified by magnetic bead separation (EasySep CD4+ cell
negative selection before [StemCell Tech, France]). To obtain
na¨ıve cells, CD4 T cells were stained with anti-CD4APCcy7, anti-
CD25PE, anti-CD44PerCPcy5.5, anti-CD62LBV421, and sorted using
FACSAria III. Cells were cultured in complete RPMI at a con-
centration of 1 × 106 cells/mL in 96-well plates coated with anti-
CD3ε at 5 μg/mL at 37°C and 5% CO2. All the cytokines and
antibodies added were supplied by eBioscience (San Diego, CA,
USA): Th0: anti-CD28 (1 μg/mL), Th1: anti-CD28 (1 μg/mL),
anti-IL-4 (5 μg/mL), and rmIL-12 (10 ng/mL); Th2: anti-CD28
(1 μg/mL), anti-IL-12 (5 μg/mL), anti-IFN-γ (5 μg/mL), and
rmIL-4 (20 ng/mL). Cells were removed from activation after 3
days and expanded in rIL-2 (20 ng/mL) for three more days in
presence of specific recombinants.
In vivo papain immunization and cell isolation from
airway and lung
Mice were exposed to 25 μg/mL of papain protease (Sigma) in
PBS or control 25 μL PBS in two doses (Supporting Informa-
tion Fig. 2A). The solution was applied drop wise to the nose
while mice were under isoflurane-induced aaesthesia. BAL were
collected by cannulating the trachea and lavaging the lungs four
times with 1.0 mL of PBS + 0.01% EDTA. The BAL cells were pel-
leted, washed, and counted for further analysis. BAL supernatants
were stored for cytokine analysis. Lung tissue was mechanically
chopped and incubated al 37°C for 30 min in DMEM medium
containing DNAse 0.5 mg/mL and Liberase 250 μg/mL (Roche,
Basel, Switzerland). Cells were prepared for RNA extraction, flow
cytometry analysis, or mechanically homogenized to obtain whole
lung supernatants for cytokine analysis.
Lung lobes were isolated and fixed in phosphate-buffered for-
malin (4% v/v) and sectioned for H&E and PAS staining per-
formed by Histopathology, Great Ormond Street Hospital. Semi-
quantitative histological assessment was performed blind by two
independent observers to score for cellular infiltration of the air-
ways and mucous production. H&E staining was scored for cel-
lular infiltration: 0, normal aspect; 1, mild infiltration around
the airway; 2, moderate infiltration around the airway; 3, strong
infiltration around the airway; and 4, severe infiltration around
the airway and extravasation, majority of airway involved. PAS
staining was scored for mucous production: 0–1, minimal; 1–2,
moderate; and 2–3, severe. Pictures were photographed by Zeiss
AxioCam digital camera with Zeiss Axioplan (NDU) Microscope,
20×Objective lens (Plan-Neofluar/0.5NA) and 40×Objective lens
(Plan-Neofluar/0.75NA) and acquired by software AxioVision v4.8
(Zeiss) and analyzed using ImageJ software.
Enzyme-linked immunosorbent assay
IFN-γ, IL-4, IL-13, and IL-27 cytokines were measured by
Ready-Set-Go! Kits (eBioscience), according to the manufacturer’s
instructions. IL-6, IL-17, IL-5, IL-10, and TNF-α were measured
by Firefly multiplex immunoassay mouse kit (Abcam, Cambridge,
UK) following manufacturer’s instructions.
Quantitative reverse transcriptase polymerase chain
reaction
RNA was extracted using Absolutely RNA miniprep kit (Agilent)
or the PicoPure kit (Applied Biosystems, USA). cDNA was synthe-
sized using High Capacity cDNA reverse transcription kit (Applied
Biosystems). cDNA samples were analyzed on the iCycler (Bio-
Rad Laboratories, Hercules, CA, USA) using SYBR Green Super-
mix (Bio-Rad) following manufacturer’s guidelines. RNA levels
obtained from each sample were measured relative to the house-
keeping gene Hprt, as described [42]. Primers were purchased
from Quantitec (Qiagen, Venlo, Netherlands).
Microarray and RNA-sequencing data analysis
For microarray, RNA was extracted using the PicoPure RNA Iso-
lation Kit (Applied Biosystems) according to the manufacturer’s
instructions from CD4+ T-cells. Microarrays were performed by
UCL Genomics on the Affymetrix Mouse Gene 1.0 ST Plat-
form (GPL6246) using standard Ambion (Invitrogen, USA) chem-
istry as described [43]. Data were analyzed as described [43],
using univariate hypothesis testing by empirical-Bayes moderated
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t-statistics, followed by removal of false positives by the false
discovery rate (FDR) method to identify DEG with fold change
greater than two, which were then filtered for those with a
minimum range of at least 250 units (RMA normalized nonlog
value) to identify 920 DEG. CCA was carried out as previously
described [39, 44, 45]. We used the CCA function of the CRAN
package library "vegan" for the calculations. All microarrays are
publically available (GEO: GSE90494).
For RNA sequencing, naive CD4+ T cells from WT spleen were
cultured in skewing conditions and RNA extracted as described
above. RNAseq was carried out as described [46] in Th0-, Th1-,
and Th2-activated CD4+ T cells at 4-h time points during 24 h
after activation. RNA was sequenced by UCL Genomics on the
Illumina Next Seq 500. Transcript expression was determined
in reads Reads Per Kilobase of transcript per Million mapped
reads (RPKM). The sequenced data are publically available (GEO:
GSE93915).
Statistics
Unpaired two-tailed student’s t test was used for statistical anal-
ysis and probabilities considered significant if p < 0.05(*),
p < 0.01(**), and p < 0.001(***).
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